🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06671769
Starting soon Phase 1

Natural Heart Health Supplement Trial

NCT06671769 · tracked via the Priya Life Science USA tracker
Sponsor
Efforia, Inc
Phase
Phase 1
Started
2025-01-15
Last updated
2024-11-04

Condition(s) studied

CholesterolCholesterol (total and HDL)

Investigational drug(s) / intervention(s)

Heart Health Supplement

Heart Health Supplement: This is a natural heart health supplement in powdered format, chocolate flavor where participants will take a daily dose.

Study summary

We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).

Eligibility

Sex
ALL
Min age
21 Years
Max age
—
Healthy volunteers
Accepted
Exclusion Criteria: * Individuals with known soy allergies * Individuals with liver disease * Pregnant or breastfeeding individuals

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Efforia - Study will be entirely online New York New York

More Efforia, Inc trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06671769 on ClinicalTrials.gov ↗ ← All trials in the USA